| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
159 |
| Employees |
- |
| Revenues (TTM) (Millions $) |
346 |
| Net Income (TTM) (Millions $) |
62 |
| Cash Flow (TTM) (Millions $) |
33 |
| Capital Exp. (TTM) (Millions $) |
9 |
Business Description
3SBio Inc. is a biotechnology company based in China. It specializes in the research, development, manufacturing, and marketing of bio-pharmaceutical products. The company focuses on therapeutic areas such as nephrology, oncology, immunology, and dermatology.
3SBio has a diverse product portfolio that includes biologics, biosimilars, and novel drugs. These products are used for the treatment of various diseases, including chronic kidney disease, cancer, autoimmune disorders, and skin conditions. The company has a strong focus on innovation and invests significant resources in research and development to develop cutting-edge therapies.
The company operates globally and has a presence in multiple countries, including China, the United States, Europe, and Australia. It has established strategic partnerships and collaborations with other pharmaceutical companies to expand its product pipeline and increase its market reach.
3SBio is committed to ensuring the highest standards of quality and safety in its products. It adheres to strict regulatory guidelines and has robust manufacturing facilities that comply with international standards. The company is known for its commitment to patient care and improving the quality of life for individuals suffering from various medical conditions.
|
%